Clinical Trial Update: Biomarkers in Clozapine-responding Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigating biomarkers in clozapine-responsive schizophrenia, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Clozapine (Clozapine)

Snippet

Sponsor: Jimmi Nielsen | Conditions: Schizophrenia, Psychosis | Phase 4 | Status: RECRUITING